[STUDIES ON THE EFFECTS OF MITOMYCIN C AGAINST PATIENTS WITH MALIGNANT TUMORS, PARTICULARLY ON THE CHANGES OF COAGULATING FACTORS].
D000818:Animals; D001779:Blood Coagulation Factors; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D001856:Bone Marrow Examination; D004285:Dogs; D004906:Erythrocyte Count; D005165:Factor V; D005167:Factor VII; D006493:Heparin; D007958:Leukocyte Count; D008111:Liver Function Tests; D016685:Mitomycin; D009369:Neoplasms / Q000628:therapy*; D010600:Pharmacology; D011517:Prothrombin Time; D012106:Research
D001779:Blood Coagulation Factors; D016685:Mitomycin; D005165:Factor V; D005167:Factor VII; D006493:Heparin
BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; BLOOD PLATELETS; BONE MARROW EXAMINATION; DOGS; ERYTHROCYTE COUNT; EXPERIMENTAL LAB STUDY; FACTOR V; FACTOR VII; HEPARIN; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; MITOMYCIN; NEOPLASM THERAPY; PHARMACOLOGY; PROTHROMBIN TIME